Lv1
10 积分 2025-07-03 加入
Safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de-novo coronary artery lesions (BIOSOLVE-II): 6 month results of a prospective, multicentre, non-randomised, first-in-man trial
11个月前
已完结
Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial
11个月前
已完结
New generation bioresorbable scaffold technologies: an update on novel devices and clinical results
11个月前
已完结
Six‐month outcomes of the XINSORB bioresorbable sirolimus‐eluting scaffold in treating single de novo lesions in human coronary artery
11个月前
已完结
Sustained Safety and Performance of the Second-Generation Sirolimus-Eluting Absorbable Metal Scaffold: Pooled Outcomes of the BIOSOLVE-II and -III Trials at 3 Years
1年前
已完结
Sustained Safety and Performance of a Second-Generation Sirolimus-Eluting Absorbable Metal Scaffold: Long-Term Data of the BIOSOLVE-II First-in-Man Trial at 5 Years
1年前
已完结
皖公网安备34019202002308
